A Resolution recognizing the month of May 2026 as "National Mammography Month" in Pennsylvania.

2025-2026 Regular Session Introduced by Lisa Baker and 25 co-sponsors

Designates May 2026 in Pennsylvania as National Mammography Month to raise awareness of breast cancer screening, without creating new laws or funding.

Referred to Rules & Executive Nominations

Summary: SR 279 (Pennsylvania) – May 2026 as National Mammography Month

Note: The bill text provided outlines historical context on Pennsylvania anti-boycott legislation and related resolutions. The specific bill SR 279 described here appears to be a non-binding resolution recognizing May 2026 as National Mammography Month in Pennsylvania, not a policy change affecting government contracts or funding. The summary below focuses on the stated purpose and potential impact of such a recognition resolution, as well as any relevant procedural notes.

1) Purpose and intent

The primary aim of SR 279 is to designate May 2026 in Pennsylvania as National Mammography Month.

The resolution serves to recognize and raise awareness of the importance of mammography screening for breast cancer detection and early intervention.

As a non-binding, commemorative measure, it does not create new state programs, funding, or regulatory requirements; rather, it signals the Legislature’s support for breast cancer screening and public health awareness.

2) Key provisions and changes

Formal recognition: The resolution designates May 2026 in Pennsylvania as National Mammography Month.

Educational intent: In its commemorative function, the resolution may encourage educational outreach about the benefits of mammography, routine screening guidelines, and access to screening services.

No policy authorization: SR 279 does not, by its terms, authorize new state duties, funding allocations, or regulatory changes.

Non-binding status: The resolution expresses the views of the Pennsylvania Senate but does not impose enforceable obligations on state agencies, healthcare providers, or employers.

3) Affected entities and beneficiaries

General public in Pennsylvania: Individuals eligible for breast cancer screening who may benefit from increased awareness and encouragement to obtain mammograms.

State healthcare stakeholders: Hospitals, clinics, and health systems in Pennsylvania may experience heightened awareness or outreach opportunities linked to National Mammography Month.

Legislators and state agencies: May use the resolution to highlight ongoing public health priorities in breast cancer screening and preventive care.

4) Procedural and timeline aspects

Current status: Referred to Rules & Executive Nominations (as of 2026-04-17). This is a standard step in the legislative process for non-binding resolutions before potential floor consideration.

Status implications: As a non-binding resolution, passage signals intent or commendation rather than creating enforceable law or policy.

Timing: If adopted, the recognition would apply to May 2026; the resolution may include language encouraging awareness campaigns during that month.

5) Context and related legislation (background vs. SR 279)

Pennsylvania has a history of anti-boycott legislation (e.g., HB 2107) and related anti-boycott resolutions and defunct bills. These measures address state contracts, investments, and blacklists related to boycotts of Israel and are separate from SR 279’s commemorative purpose.

SR 279 sits within a broader legislative environment that includes non-binding resolutions condemning or supporting various public policy themes. This resolution, however, focuses on public health awareness rather than regulatory or procurement policy.

If you’d like, I can tailor the summary to emphasize potential public health outreach steps, anticipated stakeholder engagement, or compare SR 279 to similar National Mammography Month recognitions in other states.